Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anacetrapib dose-ranging study in Japanese patients with dyslipidemia
NCT00977288Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of anacetrapib in dyslipidemia, sponsored by Merck & Co.. Started Sep 2009; status: completed.
02
Drugs
anacetrapib
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00977288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00977288.